Radiation Oncology Market Size, Share, Growth Opportunity Analysis Report by Type of Radiation Therapy (External Beam Radiation Therapy (EBRT) and Internal Beam Radiation Therapy (Brachytherapy)), Technology, Component, Treatment Type, Indication/ Cancer Type, Patient Demographics, End User and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2025–2035.
|
|
|
Segmental Data Insights |
|
|
Demand Trends |
|
|
Competitive Landscape |
|
|
Strategic Development |
|
|
Future Outlook & Opportunities |
|
Radiation Oncology Market Size, Share, and Growth
The global radiation oncology market is projected to grow from USD 6.5 Billion in 2025 to USD 16.5 Billion, with a strong CAGR of 8.9% during the forecasted period. The major drivers in the global radiation oncology market are the increased prevalence of cancer and the development of radiotherapy machines. The growing cancer burden in the world is driving the pressure to find good treatment modalities, according to WHO, more than 20 million new cancer cases were reported in 2024.
In May 2025, RefleXion Medical announced the expansion of its RefleXion X1 platform with biologically guided radiotherapy (BgRT) capabilities, enabling simultaneous tumor detection and treatment using PET signals. This approach aims to treat multiple metastatic sites in real-time. CEO Todd Powell emphasized that this innovation represents a paradigm shift in radiotherapy by making biology the target for beam guidance rather than anatomy alone.
The future of precision radiotherapy is improving the outcome of treatments; in April 2025, Elekta introduced the new Elekta Harmony Pro, an advanced linear accelerator that uses AI-enabled workflows to enable faster, more customized treatments, increasing efficiency and patient throughput. Such drivers are hastening market development by increasing the use of next-generation radiation therapy systems worldwide.
The use of AI-enabled cancer diagnostics, proton therapy systems, and oncology-related telehealth platforms represent key opportunities to the global radiation oncology market. These markets supplement radiotherapy with the intention of improving early detection, providing accurate treatment options, and remote patient management, respectively. The opportunities increase the ecosystem, promote the integration of cancer care and provide a boost to the radiation oncology market.
Radiation Oncology Market Dynamics and Trends
Driver: Increasing Integration of Imaging with Radiotherapy Systems
- The use of advanced imaging technologies in conjunction with radiotherapy systems in order to improve tumor targeting and treatment results has been a major force in the radiation oncology industry worldwide. Image-guided radiotherapy (IGRT) allows clinicians to see tumours in live mode and radically reduce the radiation dose to normal tissues, enhancing accuracy. This combined therapy is particularly useful when managing tumors that are in a sensitive or mobile location, e.g. lungs or prostate.
- In June 2025, ViewRay released the MRIdian A3 system, a hybrid of real-time MRI and linear accelerator-based treatment that enables clinicians to adjust doses of radiation during treatment. The system provides improved imaging guidance leading to lower margins and greater efficacy of hypo fractionated treatments. This type of innovation is consistent with the larger trend of personalized, adaptive radiotherapy.
- Combination of imaging and radiotherapy has increased accuracy of treatment, resulting in use of newer systems and better patient results internationally.
Restraint: High Cost and Infrastructure Requirements
- The high cost of radiotherapy equipment and other related infrastructure is one of the major market restraints in the global radiation oncology market. Establishing a modern radiation oncology center requires high capital outlays not only in the purchase of equipment such as linear accelerators or proton therapy units, but also in shielding, maintenance, and operating personnel. A special problem in low- and middle-income countries is that healthcare budgets are constrained.
- In one instance, according to Varian Medical Systems (a Siemens Healthineers company) Q1 2025 investor call, numerous emerging market tenders are frozen because they have not received their funding approvals and are worried about the cost of new installations. Budget limitations tend to slow down the process of replacing out-dated systems even in developed markets. These economic constraints restrict availability of state-of-the-art radiation treatment.
- The initial cost and complexity of operation prevents large scale adoption, especially in resource limited areas, and slows the geographic penetration of the market.
Opportunity: Growing Demand for Adaptive Radiotherapy Solutions
- The increased trend in adaptive radiotherapy is an opportunity to the radiation oncology market. Dynamic To improve accuracy and outcomes, adaptive radiotherapy dynamically modifies treatment plans as tumors change or the anatomy of the patient evolves. As more attention is paid to personalized medicine, adaptive solutions are taking center stage in the treatment of complex cancers.
- In April 2025, Accuray Incorporated released its TomoTherapy Radixact System with built-in ClearRT AI software, which allows it to automatically adapt to changes in the anatomy every day with the help of artificial intelligence. The innovation saves on planning time and enhances real-time accuracy to provide more responsive care. Treatment of tumors which are otherwise inoperable or difficult to target is also made possible with the combination of AI with adaptive radiotherapy. The accumulating evidence on the clinical utility of adaptive therapy is prompting its application in major cancer facilities in the world.
- The emergence of adaptive radiotherapy technologies is increasing clinical utility, which presents solution providers with revenue-generating growth opportunities throughout the oncology care continuum.
Key Trend: Shift Toward Hypo Fractionated Radiotherapy Protocols
- The current trend in the radiation oncology market is the transition to hypo fractionated radiotherapy regimens in which patients undergo more massive doses of radiation in fewer treatments. This approach saves time during treatment and increases patient convenience in addition to reducing health care costs. It is particularly applicable during pandemic and post-pandemic scenarios whereby a decrease in the number of hospital visits is a priority. In January 2025, IBA (Ion Beam Applications S.A.) declared it would support new hypofractionation protocols by updating software on its Proteus ONE proton delivery system to allow it to safely deliver higher doses of radiation.
- In addition, the effectiveness of shorter treatment regimens is still being proven in clinical trials including FAST-Forward in breast cancer. This trend is pushing payers, providers and patients to implement value-based, efficient care models that are transforming treatment protocols both in public and private healthcare environments.
- Throughput, cost reduction, and operational strategy redefinition across radiation oncology centers are being enhanced by adoption of hypo fractionated protocols.
Radiation Oncology Market Analysis and Segmental Data
Based on Type of Radiation Therapy, the External Beam Radiation Therapy (EBRT) Segment Retains the Largest Share
- The external beam radiation therapy (EBRT) segment commands significant market share ~38% in worldwide radiation oncology market. External beam radiation therapy (EBRT) is most needed in the radiation oncology market in the world because it is non-invasive, it can treat tumors precisely and it can be used to treat most types of cancer. EBRT is more comfortable and has shorter recovery time than surgical means. It could also be used together with the contemporary technologies, e.g., IMRT, IGRT and stereotactic body radiotherapy (SBRT), thereby, enhancing the accuracy of treatments.
- An example is when Varian announced in February 2025 the Halcyon 3.0 platform, which offers AI-assisted beam modulation and reduced set up times, and enables a more efficient delivery of high-precision EBRT to a wider range of cancer cases.
- EBRT is the modality of choice due to high versatility and constant innovation, which has greatly increased its market share in radiation oncology across the globe.
North America Dominates Global Radiation Oncology Market in 2025 and Beyond
- North America has the highest radiation oncology demand because the region has a high cancer rate, a well-developed healthcare system, and an early adoption of the latest radiotherapy equipment. The American Cancer Society estimates that 2 million new cases of cancer will occur in 2025 alone in the U.S. This has triggered tremendous investments in radiation oncology.
- In January 2025, GenesisCare USA opened new centers in the U.S. equipped with Elekta Unity MR-Linac systems to provide high-level image-guided treatment. The reimbursement rates are high and the key players are well represented to facilitate further adoption.
- In addition, the focus on precision medicine and favorable regulatory pathways in North America accelerate the delivery and implementation of new radiotherapy solutions. Cooperative programs between technology companies and medical organizations also increase access to and quality of treatment. The increased geriatric population predisposed to cancer increases the long term need of radiation-based treatment in the area.
- North America stands tall among all the regions in the world in terms of radiation oncology demand due to its advanced infrastructure, innovation and prevalence of cancer.
Radiation Oncology Market Ecosystem
Key players in the global radiation oncology market include prominent companies such as Varian Medical Systems (Siemens), Elekta AB, Accuray Incorporated, IBA Group (Ion Beam Applications), Mevion Medical Systems and Other Key Players.
The global radiation oncology market features a moderately consolidated, with Tier 1 companies such as Varian Medical Systems, Elekta, and Siemens Healthineers holding the lion’s share. Meanwhile, Accuray, Brainlab, and C-Rad, classified as Tier 2 and 3 companies, add value through specialized niche innovations. The ecosystem shows medium to high concentration, which indicates the advanced technology and capital-intensive nature of the industry. From the point of view of the porter’s five forces, the concentration of the buyers is on the moderate side because of the heavy dependence on the hospitals. On the other hand, the suppliers face high concentration due to the few specialized component providers.
Recent Development and Strategic Overview:
- In June 2025, Sanofi acquired a 16% stake in OranoMed (a subsidiary of French nuclear fuel company Orano) for €300 million to co-develop a lead-212–based alpha-emitting radiopharmaceutical targeting neuroendocrine tumors leveraging combined biopharma and nuclear expertise with FDA breakthrough designation, aiming for a possible 2026 launch.
- In June 2025, Bristol Myers Squibb announced a $1.5 billion upfront partnership with BioNTech to co-develop BNT327, a bispecific antibody combining immune activation with anti-angiogenic effects for lung cancers highlighting a strategic shift toward integrated immuno-radiotherapeutic modalities.
Report Scope
|
Detail |
|
|
Market Size in 2025 |
USD 6.5 Bn |
|
Market Forecast Value in 2035 |
USD 16.5 Bn |
|
Growth Rate (CAGR) |
8.9% |
|
Forecast Period |
2025 – 2035 |
|
Historical Data Available for |
2021 – 2024 |
|
Market Size Units |
US$ Billion for Value |
|
Report Format |
Electronic (PDF) + Excel |
|
North America |
Europe |
Asia Pacific |
Middle East |
Africa |
South America |
|
|
|
|
|
|
|
Companies Covered |
|||||
|
|
|
|
|
|
Radiation Oncology Market Segmentation and Highlights
|
Segment |
Sub-segment |
|
By Type of Radiation Therapy |
|
|
By Technology |
|
|
By Component |
|
|
By Treatment Type |
|
|
By Indication/ Cancer Type |
|
|
By Patient Demographics |
|
|
By End User |
|
Frequently Asked Questions
The global radiation oncology market was valued at USD 6.5 Bn in 2025.
The global radiation oncology market industry is expected to grow at a CAGR of 8.9% from 2025 to 2035.
The demand for the radiation oncology market is driven by the rising global cancer incidence, increasing adoption of advanced radiotherapy technologies, and a growing preference for non-invasive treatment methods. Moreover, supportive government funding, expanding healthcare infrastructure in emerging economies, and continuous innovations like image-guided and adaptive radiotherapy are further boosting market growth.
External beam radiation therapy (EBRT) contributed to the largest share of the radiation oncology market business in 2025, due to its non-invasive nature, ability to precisely target tumors, and applicability across a wide range of cancer types.
The ASEAN is among the fastest-growing countries globally.
Accuray Incorporated, Analogic Corporation, Best Theratronics, Brainlab AG, C-Rad AB, Elekta AB, Hitachi, Ltd., IBA Group (Ion Beam Applications), Lantheus Medical Imaging, Mevion Medical Systems, Nuvotec Limited., Philips Healthcare, RaySearch Laboratories, RefleXion Medical, Siemens Healthineers, Sumitomo Heavy Industries, Toshiba Medical Systems (Canon Medical Systems), Varian Medical Systems (a Siemens Healthineers company), ViewRay Inc., Zoll Medical Corporation and Other Key Players.
Table of Contents
- 1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
- 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
- 1.6.1. Open Sources
- 1.6.2. Paid Databases
- 1.6.3. Associations
- 1.7. Primary Research
- 1.7.1. Primary Sources
- 1.7.2. Primary Interviews with Stakeholders across Ecosystem
- 2. Executive Summary
- 2.1. Global Radiation Oncology Market Outlook
- 2.1.1. Radiation Oncology Market Size (Value - US$ Billion), and Forecasts, 2021-2035
- 2.1.2. Compounded Annual Growth Rate Analysis
- 2.1.3. Growth Opportunity Analysis
- 2.1.4. Segmental Share Analysis
- 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
- 2.5.1. Customer/ End Use Industry Assessment
- 2.5.2. Growth Opportunity Data, 2025-2035
- 2.5.2.1. Regional Data
- 2.5.2.2. Country Data
- 2.5.2.3. Segmental Data
- 2.5.3. Identification of Potential Market Spaces
- 2.5.4. GAP Analysis
- 2.5.5. Potential Attractive Price Points
- 2.5.6. Prevailing Market Risks & Challenges
- 2.5.7. Preferred Sales & Marketing Strategies
- 2.5.8. Key Recommendations and Analysis
- 2.5.9. A Way Forward
- 2.1. Global Radiation Oncology Market Outlook
- 3. Industry Data and Premium Insights
- 3.1. Global Healthcare & Pharmaceutical Overview, 2025
- 3.1.1. Industry Ecosystem Analysis
- 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
- 3.1.3. Regional Distribution for Healthcare & Pharmaceutical
- 3.2. Supplier Customer Data
- 3.3. Technology Roadmap and Developments
- 3.1. Global Healthcare & Pharmaceutical Overview, 2025
- 4. Market Overview
- 4.1. Market Dynamics
- 4.1.1. Drivers
- 4.1.1.1. Rising global cancer incidence necessitating non-invasive and effective treatment alternatives
- 4.1.1.2. Advancements in image-guided and adaptive radiotherapy technologies enhancing precision and safety
- 4.1.1.3. Increasing healthcare infrastructure and investment in radiotherapy equipment across both developed and emerging markets.
- 4.1.2. Restraints
- 4.1.2.1. High upfront capital costs and infrastructure requirements associated with advanced radiotherapy systems, limiting adoption in cost-sensitive regions.
- 4.1.1. Drivers
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
- 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
- 4.3.2. Tariffs and Standards
- 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Value Chain Analysis
- 4.4.1. Raw Material/ Component Suppliers
- 4.4.2. Technology Providers/ System Integrators
- 4.4.3. Radiation Oncology Equipment Manufacturers
- 4.4.4. Healthcare Providers
- 4.4.5. End Users
- 4.5. Cost Structure Analysis
- 4.5.1. Parameter’s Share for Cost Associated
- 4.5.2. COGP vs COGS
- 4.5.3. Profit Margin Analysis
- 4.6. Pricing Analysis
- 4.6.1. Regional Pricing Analysis
- 4.6.2. Segmental Pricing Trends
- 4.6.3. Factors Influencing Pricing
- 4.7. Porter’s Five Forces Analysis
- 4.8. PESTEL Analysis
- 4.9. Global Radiation Oncology Market Demand
- 4.9.1. Historical Market Size - in Value (Value - US$ Billion), 2021-2024
- 4.9.2. Current and Future Market Size - in Value (Value - US$ Billion), 2025–2035
- 4.9.2.1. Y-o-Y Growth Trends
- 4.9.2.2. Absolute $ Opportunity Assessment
- 4.1. Market Dynamics
- 5. Competition Landscape
- 5.1. Competition structure
- 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
- 5.2.1. Global Company Market Share
- 5.2.2. By Region
- 5.2.2.1. North America
- 5.2.2.2. Europe
- 5.2.2.3. Asia Pacific
- 5.2.2.4. Middle East
- 5.2.2.5. Africa
- 5.2.2.6. South America
- 5.3. Product Comparison Matrix
- 5.3.1. Specifications
- 5.3.2. Market Positioning
- 5.3.3. Pricing
- 5.1. Competition structure
- 6. Global Radiation Oncology Market Analysis, by Type of Radiation Therapy
- 6.1. Key Segment Analysis
- 6.2. Radiation Oncology Market Size (Value - US$ Billion), Analysis, and Forecasts, by Type of Radiation Therapy, 2021-2035
- 6.2.1. External Beam Radiation Therapy (EBRT)
- 6.2.1.1. 3D Conformal Radiation Therapy (3D-CRT)
- 6.2.1.2. Intensity-Modulated Radiation Therapy (IMRT)
- 6.2.1.3. Image-Guided Radiation Therapy (IGRT)
- 6.2.1.4. Stereotactic Radiosurgery (SRS)
- 6.2.1.5. Stereotactic Body Radiotherapy (SBRT)
- 6.2.1.6. Proton Beam Therapy
- 6.2.1.7. Tomotherapy
- 6.2.1.8. Others
- 6.2.2. Internal Beam Radiation Therapy (Brachytherapy)
- 6.2.2.1. Low-Dose Rate (LDR)
- 6.2.2.2. High-Dose Rate (HDR)
- 6.2.1. External Beam Radiation Therapy (EBRT)
- 7. Global Radiation Oncology Market Analysis, by Technology
- 7.1. Key Segment Analysis
- 7.2. Radiation Oncology Market Size (Value - US$ Billion), Analysis, and Forecasts, by Technology, 2021-2035
- 7.2.1. Linear Accelerators (LINACs)
- 7.2.2. Proton Therapy Systems
- 7.2.3. CyberKnife Systems
- 7.2.4. Gamma Knife Systems
- 7.2.5. Brachytherapy Afterloaders
- 7.2.6. Radiotherapy Simulators
- 7.2.7. Treatment Planning Systems (TPS)
- 7.2.8. Others
- 8. Global Radiation Oncology Market Analysis, by Component
- 8.1. Key Segment Analysis
- 8.2. Radiation Oncology Market Size (Value - US$ Billion), Analysis, and Forecasts, by Component, 2021-2035
- 8.2.1. Radiation Therapy Devices
- 8.2.2. Software (Planning, Imaging, Delivery)
- 8.2.3. Services (Maintenance, Consultation, QA)
- 9. Global Radiation Oncology Market Analysis, by Treatment Type
- 9.1. Key Segment Analysis
- 9.2. Radiation Oncology Market Size (Value - US$ Billion), Analysis, and Forecasts, by Treatment Type, 2021-2035
- 9.2.1. Curative Treatment
- 9.2.2. Palliative Treatment
- 9.2.3. Adjuvant Therapy
- 9.2.4. Neoadjuvant Therapy
- 10. Global Radiation Oncology Market Analysis, by Indication/ Cancer Type
- 10.1. Key Segment Analysis
- 10.2. Radiation Oncology Market Size (Value - US$ Billion), Analysis, and Forecasts, by Indication/ Cancer Type, 2021-2035
- 10.2.1. Breast Cancer
- 10.2.2. Lung Cancer
- 10.2.3. Prostate Cancer
- 10.2.4. Colorectal Cancer
- 10.2.5. Head and Neck Cancer
- 10.2.6. Cervical Cancer
- 10.2.7. Liver Cancer
- 10.2.8. Others (Brain, Bladder, Skin, etc.)
- 11. Global Radiation Oncology Market Analysis, by Patient Demographics
- 11.1. Key Segment Analysis
- 11.2. Radiation Oncology Market Size (Value - US$ Billion), Analysis, and Forecasts, by Patient Demographics, 2021-2035
- 11.2.1. Adult Patients
- 11.2.2. Pediatric Patients
- 11.2.3. Geriatric Patients
- 12. Global Radiation Oncology Market Analysis, by End User
- 12.1. Key Segment Analysis
- 12.2. Radiation Oncology Market Size (Value - US$ Billion), Analysis, and Forecasts, by End User, 2021-2035
- 12.2.1. Hospitals
- 12.2.2. Cancer Research Institutes
- 12.2.3. Radiotherapy Centers
- 12.2.4. Ambulatory Surgical Centers
- 12.2.5. Academic Medical Centers
- 12.2.6. Others
- 13. Global Radiation Oncology Market Analysis and Forecasts, by Region
- 13.1. Key Findings
- 13.2. Radiation Oncology Market Size (Value - US$ Billion), Analysis, and Forecasts, by Region, 2021-2035
- 13.2.1. North America
- 13.2.2. Europe
- 13.2.3. Asia Pacific
- 13.2.4. Middle East
- 13.2.5. Africa
- 13.2.6. South America
- 14. North America Radiation Oncology Market Analysis
- 14.1. Key Segment Analysis
- 14.2. Regional Snapshot
- 14.3. North America Radiation Oncology Market Size Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- 14.3.1. Type of Radiation Therapy
- 14.3.2. Technology
- 14.3.3. Component
- 14.3.4. Treatment Type
- 14.3.5. Indication/ Cancer Type
- 14.3.6. Patient Demographics
- 14.3.7. End User
- 14.3.8. Country
- 14.3.8.1. USA
- 14.3.8.2. Canada
- 14.3.8.3. Mexico
- 14.4. USA Radiation Oncology Market
- 14.4.1. Country Segmental Analysis
- 14.4.2. Type of Radiation Therapy
- 14.4.3. Technology
- 14.4.4. Component
- 14.4.5. Treatment Type
- 14.4.6. Indication/ Cancer Type
- 14.4.7. Patient Demographics
- 14.4.8. End User
- 14.5. Canada Radiation Oncology Market
- 14.5.1. Country Segmental Analysis
- 14.5.2. Type of Radiation Therapy
- 14.5.3. Technology
- 14.5.4. Component
- 14.5.5. Treatment Type
- 14.5.6. Indication/ Cancer Type
- 14.5.7. Patient Demographics
- 14.5.8. End User
- 14.6. Mexico Radiation Oncology Market
- 14.6.1. Country Segmental Analysis
- 14.6.2. Type of Radiation Therapy
- 14.6.3. Technology
- 14.6.4. Component
- 14.6.5. Treatment Type
- 14.6.6. Indication/ Cancer Type
- 14.6.7. Patient Demographics
- 14.6.8. End User
- 15. Europe Radiation Oncology Market Analysis
- 15.1. Key Segment Analysis
- 15.2. Regional Snapshot
- 15.3. Europe Radiation Oncology Market Size (Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- 15.3.1. Type of Radiation Therapy
- 15.3.2. Technology
- 15.3.3. Component
- 15.3.4. Treatment Type
- 15.3.5. Indication/ Cancer Type
- 15.3.6. Patient Demographics
- 15.3.7. End User
- 15.3.8. Country
- 15.3.8.1. Germany
- 15.3.8.2. United Kingdom
- 15.3.8.3. France
- 15.3.8.4. Italy
- 15.3.8.5. Spain
- 15.3.8.6. Netherlands
- 15.3.8.7. Nordic Countries
- 15.3.8.8. Poland
- 15.3.8.9. Russia & CIS
- 15.3.8.10. Rest of Europe
- 15.4. Germany Radiation Oncology Market
- 15.4.1. Country Segmental Analysis
- 15.4.2. Type of Radiation Therapy
- 15.4.3. Technology
- 15.4.4. Component
- 15.4.5. Treatment Type
- 15.4.6. Indication/ Cancer Type
- 15.4.7. Patient Demographics
- 15.4.8. End User
- 15.5. United Kingdom Radiation Oncology Market
- 15.5.1. Country Segmental Analysis
- 15.5.2. Type of Radiation Therapy
- 15.5.3. Technology
- 15.5.4. Component
- 15.5.5. Treatment Type
- 15.5.6. Indication/ Cancer Type
- 15.5.7. Patient Demographics
- 15.5.8. End User
- 15.6. France Radiation Oncology Market
- 15.6.1. Country Segmental Analysis
- 15.6.2. Type of Radiation Therapy
- 15.6.3. Technology
- 15.6.4. Component
- 15.6.5. Treatment Type
- 15.6.6. Indication/ Cancer Type
- 15.6.7. Patient Demographics
- 15.6.8. End User
- 15.7. Italy Radiation Oncology Market
- 15.7.1. Country Segmental Analysis
- 15.7.2. Type of Radiation Therapy
- 15.7.3. Technology
- 15.7.4. Component
- 15.7.5. Treatment Type
- 15.7.6. Indication/ Cancer Type
- 15.7.7. Patient Demographics
- 15.7.8. End User
- 15.8. Spain Radiation Oncology Market
- 15.8.1. Country Segmental Analysis
- 15.8.2. Type of Radiation Therapy
- 15.8.3. Technology
- 15.8.4. Component
- 15.8.5. Treatment Type
- 15.8.6. Indication/ Cancer Type
- 15.8.7. Patient Demographics
- 15.8.8. End User
- 15.9. Netherlands Radiation Oncology Market
- 15.9.1. Country Segmental Analysis
- 15.9.2. Type of Radiation Therapy
- 15.9.3. Technology
- 15.9.4. Component
- 15.9.5. Treatment Type
- 15.9.6. Indication/ Cancer Type
- 15.9.7. Patient Demographics
- 15.9.8. End User
- 15.10. Nordic Countries Radiation Oncology Market
- 15.10.1. Country Segmental Analysis
- 15.10.2. Type of Radiation Therapy
- 15.10.3. Technology
- 15.10.4. Component
- 15.10.5. Treatment Type
- 15.10.6. Indication/ Cancer Type
- 15.10.7. Patient Demographics
- 15.10.8. End User
- 15.11. Poland Radiation Oncology Market
- 15.11.1. Country Segmental Analysis
- 15.11.2. Type of Radiation Therapy
- 15.11.3. Technology
- 15.11.4. Component
- 15.11.5. Treatment Type
- 15.11.6. Indication/ Cancer Type
- 15.11.7. Patient Demographics
- 15.11.8. End User
- 15.12. Russia & CIS Radiation Oncology Market
- 15.12.1. Country Segmental Analysis
- 15.12.2. Type of Radiation Therapy
- 15.12.3. Technology
- 15.12.4. Component
- 15.12.5. Treatment Type
- 15.12.6. Indication/ Cancer Type
- 15.12.7. Patient Demographics
- 15.12.8. End User
- 15.13. Rest of Europe Radiation Oncology Market
- 15.13.1. Country Segmental Analysis
- 15.13.2. Type of Radiation Therapy
- 15.13.3. Technology
- 15.13.4. Component
- 15.13.5. Treatment Type
- 15.13.6. Indication/ Cancer Type
- 15.13.7. Patient Demographics
- 15.13.8. End User
- 16. Asia Pacific Radiation Oncology Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. East Asia Radiation Oncology Market Size (Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- 16.3.1. Type of Radiation Therapy
- 16.3.2. Technology
- 16.3.3. Component
- 16.3.4. Treatment Type
- 16.3.5. Indication/ Cancer Type
- 16.3.6. Patient Demographics
- 16.3.7. End User
- 16.3.8. Country
- 16.3.8.1. China
- 16.3.8.2. India
- 16.3.8.3. Japan
- 16.3.8.4. South Korea
- 16.3.8.5. Australia and New Zealand
- 16.3.8.6. Indonesia
- 16.3.8.7. Malaysia
- 16.3.8.8. Thailand
- 16.3.8.9. Vietnam
- 16.3.8.10. Rest of Asia Pacific
- 16.4. China Radiation Oncology Market
- 16.4.1. Country Segmental Analysis
- 16.4.2. Type of Radiation Therapy
- 16.4.3. Technology
- 16.4.4. Component
- 16.4.5. Treatment Type
- 16.4.6. Indication/ Cancer Type
- 16.4.7. Patient Demographics
- 16.4.8. End User
- 16.5. India Radiation Oncology Market
- 16.5.1. Country Segmental Analysis
- 16.5.2. Type of Radiation Therapy
- 16.5.3. Technology
- 16.5.4. Component
- 16.5.5. Treatment Type
- 16.5.6. Indication/ Cancer Type
- 16.5.7. Patient Demographics
- 16.5.8. End User
- 16.6. Japan Radiation Oncology Market
- 16.6.1. Country Segmental Analysis
- 16.6.2. Type of Radiation Therapy
- 16.6.3. Technology
- 16.6.4. Component
- 16.6.5. Treatment Type
- 16.6.6. Indication/ Cancer Type
- 16.6.7. Patient Demographics
- 16.6.8. End User
- 16.7. South Korea Radiation Oncology Market
- 16.7.1. Country Segmental Analysis
- 16.7.2. Type of Radiation Therapy
- 16.7.3. Technology
- 16.7.4. Component
- 16.7.5. Treatment Type
- 16.7.6. Indication/ Cancer Type
- 16.7.7. Patient Demographics
- 16.7.8. End User
- 16.8. Australia and New Zealand Radiation Oncology Market
- 16.8.1. Country Segmental Analysis
- 16.8.2. Type of Radiation Therapy
- 16.8.3. Technology
- 16.8.4. Component
- 16.8.5. Treatment Type
- 16.8.6. Indication/ Cancer Type
- 16.8.7. Patient Demographics
- 16.8.8. End User
- 16.9. Indonesia Radiation Oncology Market
- 16.9.1. Country Segmental Analysis
- 16.9.2. Type of Radiation Therapy
- 16.9.3. Technology
- 16.9.4. Component
- 16.9.5. Treatment Type
- 16.9.6. Indication/ Cancer Type
- 16.9.7. Patient Demographics
- 16.9.8. End User
- 16.10. Malaysia Radiation Oncology Market
- 16.10.1. Country Segmental Analysis
- 16.10.2. Type of Radiation Therapy
- 16.10.3. Technology
- 16.10.4. Component
- 16.10.5. Treatment Type
- 16.10.6. Indication/ Cancer Type
- 16.10.7. Patient Demographics
- 16.10.8. End User
- 16.11. Thailand Radiation Oncology Market
- 16.11.1. Country Segmental Analysis
- 16.11.2. Type of Radiation Therapy
- 16.11.3. Technology
- 16.11.4. Component
- 16.11.5. Treatment Type
- 16.11.6. Indication/ Cancer Type
- 16.11.7. Patient Demographics
- 16.11.8. End User
- 16.12. Vietnam Radiation Oncology Market
- 16.12.1. Country Segmental Analysis
- 16.12.2. Type of Radiation Therapy
- 16.12.3. Technology
- 16.12.4. Component
- 16.12.5. Treatment Type
- 16.12.6. Indication/ Cancer Type
- 16.12.7. Patient Demographics
- 16.12.8. End User
- 16.13. Rest of Asia Pacific Radiation Oncology Market
- 16.13.1. Country Segmental Analysis
- 16.13.2. Type of Radiation Therapy
- 16.13.3. Technology
- 16.13.4. Component
- 16.13.5. Treatment Type
- 16.13.6. Indication/ Cancer Type
- 16.13.7. Patient Demographics
- 16.13.8. End User
- 17. Middle East Radiation Oncology Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Middle East Radiation Oncology Market Size (Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- 17.3.1. Type of Radiation Therapy
- 17.3.2. Technology
- 17.3.3. Component
- 17.3.4. Treatment Type
- 17.3.5. Indication/ Cancer Type
- 17.3.6. Patient Demographics
- 17.3.7. End User
- 17.3.8. Country
- 17.3.8.1. Turkey
- 17.3.8.2. UAE
- 17.3.8.3. Saudi Arabia
- 17.3.8.4. Israel
- 17.3.8.5. Rest of Middle East
- 17.4. Turkey Radiation Oncology Market
- 17.4.1. Country Segmental Analysis
- 17.4.2. Type of Radiation Therapy
- 17.4.3. Technology
- 17.4.4. Component
- 17.4.5. Treatment Type
- 17.4.6. Indication/ Cancer Type
- 17.4.7. Patient Demographics
- 17.4.8. End User
- 17.5. UAE Radiation Oncology Market
- 17.5.1. Country Segmental Analysis
- 17.5.2. Type of Radiation Therapy
- 17.5.3. Technology
- 17.5.4. Component
- 17.5.5. Treatment Type
- 17.5.6. Indication/ Cancer Type
- 17.5.7. Patient Demographics
- 17.5.8. End User
- 17.6. Saudi Arabia Radiation Oncology Market
- 17.6.1. Country Segmental Analysis
- 17.6.2. Type of Radiation Therapy
- 17.6.3. Technology
- 17.6.4. Component
- 17.6.5. Treatment Type
- 17.6.6. Indication/ Cancer Type
- 17.6.7. Patient Demographics
- 17.6.8. End User
- 17.7. Israel Radiation Oncology Market
- 17.7.1. Country Segmental Analysis
- 17.7.2. Type of Radiation Therapy
- 17.7.3. Technology
- 17.7.4. Component
- 17.7.5. Treatment Type
- 17.7.6. Indication/ Cancer Type
- 17.7.7. Patient Demographics
- 17.7.8. End User
- 17.8. Rest of Middle East Radiation Oncology Market
- 17.8.1. Country Segmental Analysis
- 17.8.2. Type of Radiation Therapy
- 17.8.3. Technology
- 17.8.4. Component
- 17.8.5. Treatment Type
- 17.8.6. Indication/ Cancer Type
- 17.8.7. Patient Demographics
- 17.8.8. End User
- 18. Africa Radiation Oncology Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. Africa Radiation Oncology Market Size (Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- 18.3.1. Type of Radiation Therapy
- 18.3.2. Technology
- 18.3.3. Component
- 18.3.4. Treatment Type
- 18.3.5. Indication/ Cancer Type
- 18.3.6. Patient Demographics
- 18.3.7. End User
- 18.3.8. Country
- 18.3.8.1. South Africa
- 18.3.8.2. Egypt
- 18.3.8.3. Nigeria
- 18.3.8.4. Algeria
- 18.3.8.5. Rest of Africa
- 18.4. South Africa Radiation Oncology Market
- 18.4.1. Country Segmental Analysis
- 18.4.2. Type of Radiation Therapy
- 18.4.3. Technology
- 18.4.4. Component
- 18.4.5. Treatment Type
- 18.4.6. Indication/ Cancer Type
- 18.4.7. Patient Demographics
- 18.4.8. End User
- 18.5. Egypt Radiation Oncology Market
- 18.5.1. Country Segmental Analysis
- 18.5.2. Type of Radiation Therapy
- 18.5.3. Technology
- 18.5.4. Component
- 18.5.5. Treatment Type
- 18.5.6. Indication/ Cancer Type
- 18.5.7. Patient Demographics
- 18.5.8. End User
- 18.6. Nigeria Radiation Oncology Market
- 18.6.1. Country Segmental Analysis
- 18.6.2. Type of Radiation Therapy
- 18.6.3. Technology
- 18.6.4. Component
- 18.6.5. Treatment Type
- 18.6.6. Indication/ Cancer Type
- 18.6.7. Patient Demographics
- 18.6.8. End User
- 18.7. Algeria Radiation Oncology Market
- 18.7.1. Country Segmental Analysis
- 18.7.2. Type of Radiation Therapy
- 18.7.3. Technology
- 18.7.4. Component
- 18.7.5. Treatment Type
- 18.7.6. Indication/ Cancer Type
- 18.7.7. Patient Demographics
- 18.7.8. End User
- 18.8. Rest of Africa Radiation Oncology Market
- 18.8.1. Country Segmental Analysis
- 18.8.2. Type of Radiation Therapy
- 18.8.3. Technology
- 18.8.4. Component
- 18.8.5. Treatment Type
- 18.8.6. Indication/ Cancer Type
- 18.8.7. Patient Demographics
- 18.8.8. End User
- 19. South America Radiation Oncology Market Analysis
- 19.1. Key Segment Analysis
- 19.2. Regional Snapshot
- 19.3. Central and South Africa Radiation Oncology Market Size (Value - US$ Billion), Analysis, and Forecasts, 2021-2035
- 19.3.1. Type of Radiation Therapy
- 19.3.2. Technology
- 19.3.3. Component
- 19.3.4. Treatment Type
- 19.3.5. Indication/ Cancer Type
- 19.3.6. Patient Demographics
- 19.3.7. End User
- 19.3.8. Country
- 19.3.8.1. Brazil
- 19.3.8.2. Argentina
- 19.3.8.3. Rest of South America
- 19.4. Brazil Radiation Oncology Market
- 19.4.1. Country Segmental Analysis
- 19.4.2. Type of Radiation Therapy
- 19.4.3. Technology
- 19.4.4. Component
- 19.4.5. Treatment Type
- 19.4.6. Indication/ Cancer Type
- 19.4.7. Patient Demographics
- 19.4.8. End User
- 19.5. Argentina Radiation Oncology Market
- 19.5.1. Country Segmental Analysis
- 19.5.2. Type of Radiation Therapy
- 19.5.3. Technology
- 19.5.4. Component
- 19.5.5. Treatment Type
- 19.5.6. Indication/ Cancer Type
- 19.5.7. Patient Demographics
- 19.5.8. End User
- 19.6. Rest of South America Radiation Oncology Market
- 19.6.1. Country Segmental Analysis
- 19.6.2. Type of Radiation Therapy
- 19.6.3. Technology
- 19.6.4. Component
- 19.6.5. Treatment Type
- 19.6.6. Indication/ Cancer Type
- 19.6.7. Patient Demographics
- 19.6.8. End User
- 20. Key Players/ Company Profile
- 20.1. Accuray Incorporated
- 20.1.1. Company Details/ Overview
- 20.1.2. Company Financials
- 20.1.3. Key Customers and Competitors
- 20.1.4. Business/ Industry Portfolio
- 20.1.5. Product Portfolio/ Specification Details
- 20.1.6. Pricing Data
- 20.1.7. Strategic Overview
- 20.1.8. Recent Developments
- 20.2. Analogic Corporation
- 20.3. Best Theratronics
- 20.4. Brainlab AG
- 20.5. C-Rad AB
- 20.6. Elekta AB
- 20.7. Hitachi, Ltd.
- 20.8. IBA Group (Ion Beam Applications)
- 20.9. Lantheus Medical Imaging
- 20.10. Mevion Medical Systems
- 20.11. Nuvotec Limited
- 20.12. Philips Healthcare
- 20.13. RaySearch Laboratories
- 20.14. RefleXion Medical
- 20.15. Siemens Healthineers
- 20.16. Sumitomo Heavy Industries
- 20.17. Toshiba Medical Systems (Canon Medical Systems)
- 20.18. Varian Medical Systems (a Siemens Healthineers company)
- 20.19. ViewRay Inc.
- 20.20. Zoll Medical Corporation
- 20.21. Other Key Players
- 20.1. Accuray Incorporated
Note* - This is just tentative list of players. While providing the report, we will cover a greater number of players based on their revenue and share for each geography
Our research design integrates both demand-side and supply-side analysis through a balanced combination of primary and secondary research methodologies. By utilizing both bottom-up and top-down approaches alongside rigorous data triangulation methods, we deliver robust market intelligence that supports strategic decision-making.
MarketGenics' comprehensive research design framework ensures the delivery of accurate, reliable, and actionable market intelligence. Through the integration of multiple research approaches, rigorous validation processes, and expert analysis, we provide our clients with the insights needed to make informed strategic decisions and capitalize on market opportunities.
MarketGenics leverages a dedicated industry panel of experts and a comprehensive suite of paid databases to effectively collect, consolidate, and analyze market intelligence.
Our approach has consistently proven to be reliable and effective in generating accurate market insights, identifying key industry trends, and uncovering emerging business opportunities.
Through both primary and secondary research, we capture and analyze critical company-level data such as manufacturing footprints, including technical centers, R&D facilities, sales offices, and headquarters.
Our expert panel further enhances our ability to estimate market size for specific brands based on validated field-level intelligence.
Our data mining techniques incorporate both parametric and non-parametric methods, allowing for structured data collection, sorting, processing, and cleaning.
Demand projections are derived from large-scale data sets analyzed through proprietary algorithms, culminating in robust and reliable market sizing.
The bottom-up approach builds market estimates by starting with the smallest addressable market units and systematically aggregating them to create comprehensive market size projections.
This method begins with specific, granular data points and builds upward to create the complete market landscape.
Customer Analysis → Segmental Analysis → Geographical Analysis
The top-down approach starts with the broadest possible market data and systematically narrows it down through a series of filters and assumptions to arrive at specific market segments or opportunities.
This method begins with the big picture and works downward to increasingly specific market slices.
TAM → SAM → SOM
While analysing the market, we extensively study secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and commercial report. Secondary sources that we utilize are not only the public sources, but it is combination of Open Source, Associations, Paid Databases, MG Repository & Knowledgebase and Others.
- Company websites, annual reports, financial reports, broker reports, and investor presentations
- National government documents, statistical databases and reports
- News articles, press releases and web-casts specific to the companies operating in the market, Magazines, reports, and others
- We gather information from commercial data sources for deriving company specific data such as segmental revenue, share for geography, product revenue, and others
- Internal and external proprietary databases (industry-specific), relevant patent, and regulatory databases
- Governing Bodies, Government Organizations
- Relevant Authorities, Country-specific Associations for Industries
We also employ the model mapping approach to estimate the product level market data through the players product portfolio
Primary research/ interviews is vital in analyzing the market. Most of the cases involves paid primary interviews. Primary sources includes primary interviews through e-mail interactions, telephonic interviews, surveys as well as face-to-face interviews with the different stakeholders across the value chain including several industry experts.
| Type of Respondents | Number of Primaries |
|---|---|
| Tier 2/3 Suppliers | ~20 |
| Tier 1 Suppliers | ~25 |
| End-users | ~25 |
| Industry Expert/ Panel/ Consultant | ~30 |
| Total | ~100 |
MG Knowledgebase
• Repository of industry blog, newsletter and case studies
• Online platform covering detailed market reports, and company profiles
- Historical Trends – Past market patterns, cycles, and major events that shaped how markets behave over time. Understanding past trends helps predict future behavior.
- Industry Factors – Specific characteristics of the industry like structure, regulations, and innovation cycles that affect market dynamics.
- Macroeconomic Factors – Economic conditions like GDP growth, inflation, and employment rates that affect how much money people have to spend.
- Demographic Factors – Population characteristics like age, income, and location that determine who can buy your product.
- Technology Factors – How quickly people adopt new technology and how much technology infrastructure exists.
- Regulatory Factors – Government rules, laws, and policies that can help or restrict market growth.
- Competitive Factors – Analyzing competition structure such as degree of competition and bargaining power of buyers and suppliers.
Multiple Regression Analysis
- Identify and quantify factors that drive market changes
- Statistical modeling to establish relationships between market drivers and outcomes
Time Series Analysis – Seasonal Patterns
- Understand regular cyclical patterns in market demand
- Advanced statistical techniques to separate trend, seasonal, and irregular components
Time Series Analysis – Trend Analysis
- Identify underlying market growth patterns and momentum
- Statistical analysis of historical data to project future trends
Expert Opinion – Expert Interviews
- Gather deep industry insights and contextual understanding
- In-depth interviews with key industry stakeholders
Multi-Scenario Development
- Prepare for uncertainty by modeling different possible futures
- Creating optimistic, pessimistic, and most likely scenarios
Time Series Analysis – Moving Averages
- Sophisticated forecasting for complex time series data
- Auto-regressive integrated moving average models with seasonal components
Econometric Models
- Apply economic theory to market forecasting
- Sophisticated economic models that account for market interactions
Expert Opinion – Delphi Method
- Harness collective wisdom of industry experts
- Structured, multi-round expert consultation process
Monte Carlo Simulation
- Quantify uncertainty and probability distributions
- Thousands of simulations with varying input parameters
Our research framework is built upon the fundamental principle of validating market intelligence from both demand and supply perspectives. This dual-sided approach ensures comprehensive market understanding and reduces the risk of single-source bias.
Demand-Side Analysis: We understand end-user/application behavior, preferences, and market needs along with the penetration of the product for specific application.
Supply-Side Analysis: We estimate overall market revenue, analyze the segmental share along with industry capacity, competitive landscape, and market structure.
Data triangulation is a validation technique that uses multiple methods, sources, or perspectives to examine the same research question, thereby increasing the credibility and reliability of research findings. In market research, triangulation serves as a quality assurance mechanism that helps identify and minimize bias, validate assumptions, and ensure accuracy in market estimates.
- Data Source Triangulation – Using multiple data sources to examine the same phenomenon
- Methodological Triangulation – Using multiple research methods to study the same research question
- Investigator Triangulation – Using multiple researchers or analysts to examine the same data
- Theoretical Triangulation – Using multiple theoretical perspectives to interpret the same data
